EXAS
Exact Sciences Corp
Price:  
100.90 
USD
Volume:  
19,257,964.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EXAS WACC - Weighted Average Cost of Capital

The WACC of Exact Sciences Corp (EXAS) is 8.2%.

The Cost of Equity of Exact Sciences Corp (EXAS) is 8.70%.
The Cost of Debt of Exact Sciences Corp (EXAS) is 5.50%.

Range Selected
Cost of equity 7.60% - 9.80% 8.70%
Tax rate 1.00% - 1.30% 1.15%
Cost of debt 4.00% - 7.00% 5.50%
WACC 7.0% - 9.3% 8.2%
WACC

EXAS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.82 0.89
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.60% 9.80%
Tax rate 1.00% 1.30%
Debt/Equity ratio 0.2 0.2
Cost of debt 4.00% 7.00%
After-tax WACC 7.0% 9.3%
Selected WACC 8.2%

EXAS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for EXAS:

cost_of_equity (8.70%) = risk_free_rate (4.15%) + equity_risk_premium (5.10%) * adjusted_beta (0.82) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.